• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Liver magnetic resonance imaging for evaluation of response to treatment after stereotactic body radiation therapy of hepatocellular carcinoma

    2022-10-08 05:42:36AlessandroSerafiniValeriaRuggeriRiccardoInchingoloMarcoGattiAlessiaGuarneriCesareMainoDavideIppolitoLuigiGrazioliUmbertoRicardiRiccardoFaletti
    World Journal of Hepatology 2022年9期

    Alessandro Serafini, Valeria Ruggeri, Riccardo Inchingolo, Marco Gatti, Alessia Guarneri, Cesare Maino,Davide Ippolito, Luigi Grazioli, Umberto Ricardi, Riccardo Faletti

    Alessandro Serafini, Marco Gatti, Riccardo Faletti, Department of Surgical Sciences, University of Turin, Turin 10126, Italy

    Valeria Ruggeri, Department of Radiology, University of Brescia, Brescia 25123, Italy

    Riccardo lnchingolo, Interventional Radiology Unit, Miulli Hospital, Acquaviva Delle Fonti 70124, Italy

    Alessia Guarneri, Umberto Ricardi, Department of Oncology-Radiation Oncology, University of Turin, Turin 10126, Italy

    Cesare Maino, Davide lppolito, Department of Diagnostic Radiology, University of Milano-Bicocca, Monza 20900, Italy

    Luigi Grazioli, Department of Radiology, Spedali Civili, University of Brescia, Brescia 25023, Italy

    Abstract BACKGROUND Although stereotactic body radiation therapy (SBRT) is increasingly used, its application has not yet been regulated by the main international guidelines, leaving the decision to multidisciplinary teams.AIM To assess magnetic resonance imaging (MRI) features of hepatocellular carcinoma (HCC) treated with SBRT, highlighting the efficacy of the treatment and the main aspects of the lesion before and after the procedure.METHODS As part of a retrospective study, 49 patients who underwent SBRT for HCC between January 2013 and November 2019 were recruited. Each patient underwent a pre-treatment MRI examination with a hepatospecific contrast agent and a similar followup examination within 6 mo of therapy. In addition, 22 patients underwent a second follow-up examination after the first 6 mo. The following characteristics were analysed: Features analysed compared to pre-treatment MRI examination, presence or absence of infield and outfield progression, ring-like enhancement, signal hyperintensity in T2-weighted sequences in the perilesional parenchyma, capsular retraction, and "band" signal hypointensity in T1-weighted gradient echo fat saturated sequences obtained during hepatobiliary excretion.RESULTS Signal hyperintensity in the T2-weighted sequences showed a statistically significant reduction in the number of lesions at the post-SBRT first control (P = 0.0006). Signal hyperintensity in diffusionweighted imaging-weighted sequences was decreased at MRI first control (P < 0.0001). A statistically significant increase of apparent diffusion coefficient values from a median of 1.01 to 1.38 at the first post-control was found (P < 0.0001). Capsular retraction was increased at the late evaluation (P = 0.006). Band-like signal hypointensity in the hepatobiliary phase was present in 94% at the late control (P = 0.006). The study of the risk of outfield progression vs infield progression revealed a hazard ratio of 9.CONCLUSION The efficacy of SBRT should be evaluated not in the first 6 mo, but at least 9 mo post-SBRT, when infield progression persists at very low rates while the risk of outfield progression increases significantly.

    Key Words: Hepatocellular carcinoma; Stereotactic body radiation therapy; Magnetic resonance imaging; Histopatology; Outcome; Radiology

    lNTRODUCTlON

    Although stereotactic body radiation therapy (SBRT) is increasingly used, its application has not yet been regulated by the main international guidelines, leaving the decision to multidisciplinary teams. Lack of diffusion and standardization of treatment indications makes the radiological definition of outcome particularly complex and not completely concordant with the main therapy evaluation systems (modified Response Evaluation Criteria in Solid Tumors [mRECIST] and European Association for the Study of the Liver [EASL]). By analysing the magnetic resonance imaging (MRI) semeiological characteristics of the hepatocellular carcinoma (HCC) lesions treated by SBRT and the remaining liver parenchyma, it would be possible to evaluate further evolution over time and changes in the diagnostic process following therapy[1].

    In addition, search of possible correlations between MRI findings and clinical, laboratory, and radiotherapy data could help to prevent radio-induced liver damage and to implement customized treatment planning. This has made it possible to use this treatment in different stages of HCC, both in patients with early-stage unifocal disease and in patients not eligible for other loco-regional therapies and for palliative purposes[2,3].

    From a technical point of view, the number of target lesions as well as their location within the liver are potential limitations in treatment planning and dose distribution. A minimum distance of at least 5 mm of the target HCCs from adjacent hollow viscera is recommended, otherwise the dose has to be reduced to match tolerance of neighboring organs.

    Semeiotic characteristics of SBRT-treated lesions differ from the imaging of other locoregional therapies: Whereas the latter results in immediate devascularization of tumor, radiotherapy leads to histological changes in the lesion and surrounding parenchyma that are gradual over time. Reflecting evolution of histological changes, an acute, subacute, or chronic stage can also be distinguished[4-10].

    The main aim of the study was to analyse MRI features of HCC lesions treated by SBRT and the remaining liver parenchyma, to monitor how these properties evolve over time and how these aspects may modify subsequent diagnostic course of therapy.

    MATERlALS AND METHODS

    Patient population

    A retrospective observational study was conducted in 49 patients (mean age 64.44 years, range 48.71-84.51), 22 females and 27 males, undergoing radiotherapy between January 2013 and November 2019.

    In 29 (59%) patients, SBRT was chosen as the first treatment option, and in 20 (41%) patients, it was in combination with previous locoregional treatments on the same lesion. Six (12%) of these patients subsequently underwent liver transplantation (bridge therapy).

    Sixty-one lesions were treated; among those, 42 were newly diagnosed HCCs and 19 were focal lesions that had already undergone previous treatment and were therefore attributable to persistent or recurrent disease.

    In the period between January 2013 and June 2020, each patient underwent an MRI examination with a hepatospecific contrast agent prior to treatment, and a similar follow-up examination within 6 mo of therapy (mean time 4 mo). In addition, 22 patients (a total of 36 lesions) underwent a second follow-up after the first 6 mo (mean time 9 mo).

    Imaging protocol

    All MRI examinations were performed with 1.5 T equipment (Philips Achieva), with a hepatospecific contrast agent (Primovist 0.25 mmol/mL, Bayer Schering Pharma, Berlin, Germany) infused at a dose of 0.1 mL/kg with a flow rate of 2 mL/sec.

    Imaging analysis before treatment

    The acquired images were re-evaluated using the PACS system (Synapse PACS, Tokyo, Japan) by a radiologist with 15 years of experience in abdominal MRI.

    For each lesion, the following characteristics were analysed and catalogued: Newly diagnosed HCC or previously treated HCC (persistence or recurrence of disease); Liver segment; Centroparenchymal or subcapsular location (distance from glissonian surface ≤ 10 mm); Diameter of hypervascularised tissue in the arterial phase; Diameter of the lesion in basal (T1-weighted in-phase and out-of-phase) sequences; Diameter in hepatobiliary excretory phase sequences; Average lesion diameter; Presence or absence of signal hyperintensity in the T2-weighted sequences, in relation to the surrounding parenchyma; Presence or absence of signal enhancement on diffusion-weighted imaging (DWI); and apparent diffusion coefficient (ADC) value (obtained by manually positioned region of interest [ROI]).

    Radiotherapeutic data analysis

    All lesions that did not show an increase in size or contrast-enhancement intensity in the arterial phase were considered free of progressing disease, and therefore treatment was assessed as effective. Tumor staging was performed according to the BCLC system. Pre-treatment Child-Pugh score, pretreatment ALBI, occurrence of RILD, Child-Pugh score variation after treatment, ALBI change after treatment, total liver volume, and planning target volume (PTV) were also assessed.

    Imaging analysis after treatment

    The following features were analysed in the post-treatment MRI examinations: Features analysed on pre-treatment MRI examination; Presence or absence of infield progression: Signs of disease progression within the treated field (increase in size and/or increase in intensity of arterial contrast-enhancement); Presence or absence of outfield progression: Signs of disease progression outside the radio-treated field according to mRECIST criteria; Presence or absence of ring-like enhancement (altered vascularity of the parenchyma adjacent to the treated lesion); Presence or absence of signal hyperintensity in T2-weighted sequences in the perilesional parenchyma; Presence or absence of capsular retraction; Presence or absence of "band" signal hypointensity in T1-weighted gradient echo fat saturated sequences obtained in the perilesional parenchyma; T1-weighted sequences obtained during hepatobiliary excretion of irradiated parenchyma; Calculation of the volume of "band" area in T1-weighted gradient echo fat saturated sequences acquired during hepatobiliary excretion by manual segmentation using polygonal ROIs, using the OsiriX DICOM Viewer software. A retrospective analysis was performed comparing pre-treatment MRI characteristics with subsequent follow-ups.

    RESULTS

    Almost 55.7% of the treated lesions had a subcapsular location; the distribution in the different hepatic segments was as follows: 3 in S1, 4 in S2, 2 in S3, 8 in S4, 10 in S5, 5 in S6, 9 in S7, and 20 in S8 (Figure 1-5).

    Figure 1 Change in lesion diameter. MR: Magnetic resonance.

    Figure 2 Tissue diameter with wash-in at pre-stereotactic body radiation therapy and follow-ups. MR: Magnetic resonance.

    Figure 3 Variation in lesion diameters over time in basal, arterial, and hepatobiliary excretion phases.

    Figure 4 Frequency of signal hyperintensity in T2-weighted and diffusion-weighted imaging sequences. MR: Magnetic resonance; DWI: Diffusion-weighted imaging.

    Figure 5 Apparent diffusion coefficient value at pre-stereotactic body radiation therapy and follow-ups. MR: Magnetic resonance; ADC: Apparent diffusion coefficient.

    The average diameter of the lesions was 17 mm (SD 13-24mm), a value that was significantly reduced both at the first control (10 mm, SD 11-20mm) and at the second follow-up (10 mm, SD 7-15mm) (Table 1).

    Five (8.2%) out of 61 lesions were hypovascular HCC. The remaining lesions showed typical postcontrast features with a mean diameter of 17 mm (range 12-24 mm), with a statistically significant reduction at follow-up (Figure 6).

    Figure 6 Comparison of changes in T2-weighted and diffusion-weighted imaging findings and apparent diffusion coefficient values over time. ADC: Apparent diffusion coefficient; DWI: Diffusion-weighted imaging; T2W: T2-weighted; SBRT: Stereotactic body radiation therapy.

    Both the diameter during the hepatobiliary phase and in basal T1 weighted sequences underwent a size reduction at both controls (Figure 7).

    Figure 7 Frequency of perilesional parenchyma findings. MR: Magnetic resonance; HBP: Hepatobiliary phase.

    On pre-treatment MRI, signal hyperintensity in the T2-weighted sequences was found in 62% of lesions, but it was only 30% at the post-SBRT first control, with a statistically significant reduction in the number of lesions (P= 0.0006).

    Signal hyperintensity in DWI-weighted sequences was found in 68% of lesions and in only 18% at MRI first control (P <0.0001). For both T2 and DWI variations, no statistically significant changes were found between first and second MRI controls (Figure 8).

    Figure 8 Risk of presenting infield and outfield progression over time.

    These variations were associated with a statistically significant increase of ADC values, which increased from a median of 1.01 at the pre-treatment examination to 1.38 at the first post-control (P <0.0001).

    In most of the lesions, the typical characteristics of the action of SBRT were identified. In particular, at the first MRI examination, 82% of the lesions showed ring-like enhancement and 84% perilesional hyperintensity in T2-weighted sequences. These percentages tended to decrease at the second MRI examination (69% and 75%, respectively) (Figure 9).

    Figure 9 lnfield and outfield progression and impact on survival.

    Capsular retraction was evident in 33% of cases at the first control, a features that significantly increased to 64% at the late evaluation (P= 0.006).

    Band-like signal hypointensity in the hepatobiliary phase was present at the first control in 95% of cases and in 94% at the late control (P= 0.006). The mean volume of the area of hypointensity calculated by manual segmentation was 85.47 cm3(range 15.21-248.16) (Figure 10).

    Figure 10 Relationship between hepatobiliary phase hypointensity area and planning target volume. HBP: Hepatobiliary phase.

    Considering the mRECIST criteria for evaluation of response to therapy, at the first examination signs of infield progression were observed in 5% of cases (3 lesions), while it was 18% for outfield progression signs (Figure 11).

    Figure 11 T2-weighted hyperintensity and diffusion-weighted imaging signal percentage at pre-stereotactic body radiation therapy and follow-ups. T2W: T2-weighted; DWI: Diffusion-weighted imaging.

    At the second MRI check-up, only one (3%) case of infield progression and 19 (28%) cases of outfield progression were observed (Figure 12).

    The study of the risk of outfield progressionvsinfield progression revealed a hazard ratio of 9.

    The risk increased as time progressed, with a sharp increase in the cumulative outfield progression hazard of around 9 after the end of therapy, as shown by the Kaplan-Meier-curve study (Figure 13).

    The time free from progression through the Kaplan-Meier curve showed a plateau of onset of infield progression around 9 mo, an interval in which outfield progression tended to increase.

    A direct relationship was also found between the area of band hypointensity during hepatobiliary excretion calculated by segmentation and PTV.

    The two volumes were linked by a parabolic correlation: Up to certain volumes of PTV, the area of hypointensity also increased in a directly proportional manner. For particularly high PTV values (greater than 300 cm3), the hepatic reaction area remained at significantly lower values.

    No further statistically significant correlations were found between the available clinical data, the radiotherapy data obtained, and the radiological findings.

    DlSCUSSlON

    In the acute stage (1-3 mo post-SBRT), typical peripheral hyperarterization can be seen, which persists or subsides in the subsequent post-contrast phases, referred to as ring-like enhancement. These changes imply the phenomena of venous congestion and reactive hyperemia in the treated area[10].

    In the subacute stage (3-6 mo post-SBRT), the parenchyma involved shows relative hypoattenuation in basal and portal acquisitions, with progressive enhancement in the late phase, related to the occlusion of the centrolobular veins and reduced intravenous contrast clearance[6].

    In the chronic stage (more than 6 mo after treatment), imaging will reveal changes caused by radioinduced fibrosis[6,11].

    Table 1 Magnetic resonance imaging characteristics at pre- and post- stereotactic body radiation therapy follow-ups

    The study showed the effectiveness of the treatment in controlling local disease, in particular, as already described in the literature, the reduction in the diameters of the lesion assessed (arterial, hepatobiliary, and basal sequences) also becomed increasingly marked at the controls following the first[5,6].

    This phenomenon is attributable to microscopic phenomena due to venocclusion that leads to fibrosis and collapse of the liver lobules at a late stage, and a reduced nutrient supply to the lesion and a progressive volumetric reduction of the whole radio-treated parenchyma[12,13].

    In addition to the analysis of the classical criteria for locoregional treatment, the study focused on the analysis of signal intensities in the T2- and DWI-weighted sequences. Both sequences provide information about the nature of the tissue and the cellularity of the lesion and are therefore useful "sentinel" parameters of treatment outcome.

    Signal hyperintensity both in the long TR and DWI sequences tended to decrease at the first control, remaining stable at subsequent controls, showing isointensisty to the surrounding liver parenchyma[6,10].

    There is a statistically significant increase in the ADC values measured before and after SBRT, probably due to a reduction in the cellularity of the lesions due to necrosis.

    As already described by Oldriniet al[10], persistence of arterial enhancement after stereotactic radiotherapy is common. In particular, arterial enhancement persisted in our population, but its diameter tended to decrease over time, probably due to progressive and slow necrosis and intralesional gigantocellular reaction. If this hypervascularisation, especially in a short-distance follow-up, was to be assessed in the same way as other locoregional therapies according to mRECIST criteria, it would be considered as a persistence of viable tissue and evaluated as ineffective[9,10]. This is in contradiction with what was reported in the literature, attesting to a percentage of complete response to SBRT that tends to progressively increase up to 90% at 12-24 mo after treatment, a figure confirmed by our study in which infield progression at the second control was 3%.

    Figure 12 Stereotactic body radiation therapy planning for hepatocellular carcinoma. A: Radiotherapy treatment planning with visualization of clinical target volume (pink line), planning target volume (red line), and areas of decreasing isodose; B: 3D rendering of the radiation beam and its incidence on the patient once positioned on the couch; C-E: Fusion Imaging of pre-stereotactic body radiation therapy planning (clinical target volume, pink line; planning target volume, red line; Isodose, 50% blue line) with magnetic resonance imaging images of the hepatobiliary excretion phase obtained 6 mo after the end of treatment. Band-like hypodensity during hepatobiliary excretion, an expression of functional resentment of the radio-treated parenchyma, is superimposed on the planning target volume area.

    For a correct interpretation of post-procedural imaging, it is essential to recognize features in the periinjury parenchyma and how they change over time: Peripheral hypervascularisation, signal hyperintensity in long TR sequences, and band hypointensity in the hepatobiliary excretion phase.

    In the context of computed tomography (CT), the imaging characteristics of focal hepatic reaction have been well described. In the immediate post-treatment, hyperdensity occurs in early vascular phase as a consequence of sinusoidal congestion and reduced venous drainage, which gradually subsides in the portal and late phases. This may make it difficult to distinguish any persistence of hypervascularised lesional tissue in the arterial phase.

    Over time, as fibrosis sets in, there will be contrastographic impregnation of the closely packed parenchyma closely contiguous to the lesion, included in the field of irradiation in the late stages[14].

    The above contrastographic features, defined as "ring-like" enhancement, were similarly present in the MRI survey of our population.

    Associated with this aspect is the signal hyperintensity of the treated areas in the acquisitions with T2-weighted and fat saturated T2-weighted sequences, which is also an indicator of radio-induced venoocclusive damage, which in the earliest phases is due to oedema and hyperemia, and with time to fibrosis[15].

    This latter factor is particularly evident in the phenomenon of capsular retraction, present in 64% of cases at the late follow-up.

    All these described elements confirm the data available in the literature on the capability of multiparametric MRI in the evaluation of locoregional hepatic therapy both in terms of post-procedural control and follow-up.

    The use of liver specific contrast agents, based on the functional alteration of the hepatocytes, allows precise delineation of the irradiated field, which will appear hypointense during excretion, with a typical "band" configuration[7,8,16]. This alteration further highlights how radiotherapy-induced structural changes in the liver through veno-venous disease can have a negative impact on the liver's immune system.

    We have also found a direct correlation between the focal hepatic reaction volume calculated by segmentation and the PTV programmed by radiotherapy of the parabolic type.

    The fact that beyond a certain PTV there is not an equal increase in the volume of focal hepatic reaction area could be explained by two factors, one of which is closely linked to the MRI method, which does not allow adequate quantification of the parenchyma. The other explanation could be due to the fibrotic response of the liver: Greater fibrosis in absolute terms results in a greater reduction in liver volume, thus negatively affecting the quantification of the area of hypointensity. According to some authors, this association could be exploited from a clinical-radiotherapeutic point of view both to assess the accuracy of centering and possibly modify it by reducing radio-induced damage, and to quantify "invivo" radiation-induced liver damage and use it as a quantitative biomarker of hepatotoxicity[17-20] .

    Nevertheless, the integration of liver function parameters and MRI-quantifiable liver damage might in the future allow further customised dose delivery or provide additional information to the radiologist in the post-therapeutic evaluation, so as to identify possible biomarkers predictive of liver damage.

    However, this finding, which can be obtained from the earliest post-treatment controls, underlines the technical accuracy of the procedure.

    In our population, no correlation was found between the occurrence of toxicity, the change in blood values, and the radiological findings described.

    The stability of these characteristics of good response to treatment and frequency of infield progression is concomitant with the rise of the frequency curve of outfield progression, which from the 9th month onwards is 9 times more frequent than local progression. This finding could lay a basis for different follow-up timing in patients treated by SBRT.

    It is in fact known that histological changes cause long-term radiological effects, therefore delaying the first follow-up in selected patients beyond the usual 6 mo (all too often not respected) would allow radiologist to express more confidence in the treatment region and at the same time have a greater chance of detecting new liver lesions, thus allowing a better correct staging.

    This study showed the effectiveness of treatment in controlling local disease; indeed, while infield progression decreased from 5% to 3% of the population at subsequent controls, outfield progression tended to increase (from 18% to 28%). However, although it is increasingly used in clinical practice today, the assessment of its effects by MRI is still lacking.

    Limitations of this work are undoubtedly its retrospective nature. This leads both to a lack of systematic planning of the diagnostic procedure of the patients, which sometimes results in an incorrect and non-standardised timing, and to a low population size, since many patients, especially in the follow-ups after the first one, undergo CT scans. Moreover, given the highly differentiated indications, patients undergoing SBRT are a particularly heterogeneous population including individuals with very different lesion sizes and stages. It is therefore clear that this does not allow an indication of the impact of the treatment on survival.

    In addition, as a treatment is particularly effective in controlling local disease, it is not possible to create two comparative subpopulations in order to identify any prognostic or predictive indicators of response to treatment.

    CONCLUSlON

    In conclusion, our study emphasized the role of liver MRI after SBRT for HCC: A multiparametric approach using a liver specific contrast agent provides more information about lesion and liver parenchyma changes compared to conventional CT studies. The direct correlation between the area of hypointensity in the hepatobiliary phase and the PTV is indicative of the accuracy of the radiotherapy treatment and useful to define the infield and outfield progression of the disease.

    Figure 13 Hepatocellular carcinoma in a 75-year-old man treated with stereotactic body radiation therapy. A and B: Diffusion-weighted imaging signal of a lesion located in segment VII, before and after treatment. In the pre-therapy evaluation, the nodule presented a marked narrowing of the diffusion of water molecules, a feature no longer present at post-stereotactic body radiation therapy (SBRT) examination; C: Hepatocellular carcinoma nodule located in segment VII characterized by intermediate signal on T2-weighted imaging; D and E: Initial capsular retraction (white arrow) was already evident at the first post-SBRT magnetic resonance examination and particularly evident at the 9 mo follow-up; F and G: SBRT outcomes characterised by an area of "band" hypodensity in the hepatic excretion phase in the axial and coronal sequences, corresponding to shaded hyperintensity in the T2-weighted sequences with the same distribution and morphology; H: These findings are an expression of treatment-induced fibrosis as demonstrated by the histological finding, where postradiotherapy fibrotic tissue can be identified after liver transplantation.

    ARTlCLE HlGHLlGHTS

    Research background

    Although stereotactic body radiation therapy (SBRT) is increasingly used, its application has not yet been regulated by the main international guidelines, leaving the decision to multidisciplinary teams.

    Research motivation

    Literature is lacking in works assessing the role of liver magnetic resonance imaging (MRI) in the evaluation of hepatocellular carcinoma (HCC) treated by SBRT.

    Research objectives

    To analyse MRI features of HCC lesions treated by SBRT and monitor how these properties evolve over time and how these aspects may modify subsequent diagnostic course of therapy.

    Research methods

    A retrospective observational study was conducted in 49 patients (mean age 64.44 years, range 48.71-84.51), 22 females and 27 males, undergoing radiotherapy between January 2013 and November 2019.

    Research results

    The most significant results came from the evaluation of infield and outfield progression. The risk increased as time progressed, with a sharp increase in the cumulative outfield progression hazard of around 9 after the end of therapy, as shown by the Kaplan-Meier curve study.

    Research conclusions

    A multiparametric approach using a liver specific contrast agent provides more information about lesion and liver parenchyma changes compared to conventional computed tomography studies. The direct correlation between the area of hypointensity in the hepatobiliary phase and the PTV is useful to define the infield and outfield progression of the disease.

    Research perspectives

    Future studies should enlarge the sample of patients and perform further follow-ups for the patients who have already undergone the first two checks.

    FOOTNOTES

    Author contributions:All authors equally contributed to this paper with conception and design of the study, literature review and analysis, manuscript drafting, critical revision, and editing, and approval of the final version.

    lnstitutional review board statement:This retrospective observational study was previously approved by the Intercompany Ethics Committee of the City of Health and Science of Turin.

    lnformed consent statement:Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.

    Conflict-of-interest statement:All the authors are aware of the content of the manuscript and have no conflict of interest to disclose.

    Data sharing statement:Technical appendix, statistical code, and dataset available from the corresponding author at riccardoin@hotmail.it. Consent was not obtained but the presented data are anonymized and risk of identification is low.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin:Italy

    ORClD number:Alessandro Serafini 0000-0002-4992-4824; Valeria Ruggeri 0000-0002-3231-0754; Riccardo Inchingolo 0000-0002-0253-5936; Marco Gatti 0000-0001-8168-5280; Alessia Guarneri 0000-0003-1711-3645; Cesare Maino 0000-0002-5742-802X; Davide Ippolito 0000-0002-2696-7047; Luigi Grazioli 0000-0002-2345-1571; Umberto Ricardi 0000-0003-4406-7621; Riccardo Faletti 0000-0002-8865-8637.

    S-Editor:Wang LL

    L-Editor:Wang TQ

    P-Editor:Cai YX

    又黄又爽又刺激的免费视频.| 国产综合懂色| 99在线人妻在线中文字幕| 亚洲一区二区三区色噜噜| 午夜精品一区二区三区免费看| 丝袜美腿在线中文| 最好的美女福利视频网| 国产亚洲精品av在线| 中文字幕久久专区| 51国产日韩欧美| 免费高清视频大片| 久久热精品热| 色综合婷婷激情| 国产单亲对白刺激| 一区二区三区免费毛片| 午夜福利高清视频| 男人和女人高潮做爰伦理| 99久久中文字幕三级久久日本| 日韩在线高清观看一区二区三区 | 免费大片18禁| 波多野结衣高清无吗| 国内精品久久久久精免费| 嫁个100分男人电影在线观看| 欧美一区二区精品小视频在线| 精品久久久久久成人av| 嫩草影院新地址| 999久久久精品免费观看国产| 尤物成人国产欧美一区二区三区| 免费观看人在逋| 色哟哟哟哟哟哟| 欧美极品一区二区三区四区| 亚洲av熟女| 亚洲成人精品中文字幕电影| 少妇的逼水好多| 午夜激情福利司机影院| 在现免费观看毛片| 亚洲无线在线观看| 日本五十路高清| 欧美区成人在线视频| 999久久久精品免费观看国产| 亚洲乱码一区二区免费版| 日日撸夜夜添| 国产精品女同一区二区软件 | 亚洲av二区三区四区| 成人av一区二区三区在线看| 精品人妻1区二区| 色在线成人网| 麻豆久久精品国产亚洲av| 免费黄网站久久成人精品| 国产成人影院久久av| 亚洲内射少妇av| 九九久久精品国产亚洲av麻豆| 悠悠久久av| 日韩,欧美,国产一区二区三区 | 性欧美人与动物交配| 成人无遮挡网站| 免费高清视频大片| 国内揄拍国产精品人妻在线| 国产极品精品免费视频能看的| 亚洲精华国产精华液的使用体验 | 欧美日韩黄片免| 少妇熟女aⅴ在线视频| 人妻丰满熟妇av一区二区三区| 欧美另类亚洲清纯唯美| 亚洲四区av| 亚洲av熟女| 久久久久久国产a免费观看| 黄色女人牲交| 一区二区三区高清视频在线| 给我免费播放毛片高清在线观看| 欧美成人免费av一区二区三区| 校园春色视频在线观看| 国产黄片美女视频| 亚洲欧美精品综合久久99| 一夜夜www| 深夜精品福利| 午夜福利在线在线| 国产亚洲精品久久久久久毛片| 中文字幕av在线有码专区| 国产aⅴ精品一区二区三区波| 亚洲一区高清亚洲精品| 嫁个100分男人电影在线观看| 久久久久久大精品| 日韩中字成人| 中文亚洲av片在线观看爽| 国产成人一区二区在线| 真人做人爱边吃奶动态| 日本在线视频免费播放| 1024手机看黄色片| 中文字幕熟女人妻在线| www日本黄色视频网| 身体一侧抽搐| 国产探花极品一区二区| 国产精品电影一区二区三区| 干丝袜人妻中文字幕| 国产精品久久视频播放| 最近中文字幕高清免费大全6 | 一区二区三区免费毛片| 亚洲七黄色美女视频| 嫩草影院精品99| 亚洲精品粉嫩美女一区| av视频在线观看入口| 亚洲av第一区精品v没综合| 亚洲内射少妇av| 99久久中文字幕三级久久日本| 草草在线视频免费看| 亚洲欧美日韩无卡精品| av中文乱码字幕在线| 亚洲专区中文字幕在线| 三级国产精品欧美在线观看| 亚洲av二区三区四区| 国产精品乱码一区二三区的特点| 美女被艹到高潮喷水动态| 精品久久久久久久久久免费视频| 直男gayav资源| 两个人视频免费观看高清| 亚洲av免费在线观看| 午夜免费成人在线视频| 日韩一本色道免费dvd| 两个人的视频大全免费| 亚洲国产精品sss在线观看| 日本精品一区二区三区蜜桃| 女生性感内裤真人,穿戴方法视频| 香蕉av资源在线| 午夜免费成人在线视频| av.在线天堂| 中文亚洲av片在线观看爽| 成年女人看的毛片在线观看| 久久精品91蜜桃| 亚洲人成网站在线播放欧美日韩| 亚洲欧美日韩东京热| 人妻制服诱惑在线中文字幕| 国产免费男女视频| 搞女人的毛片| 中文资源天堂在线| 国产亚洲精品综合一区在线观看| av在线老鸭窝| 啦啦啦观看免费观看视频高清| 又黄又爽又刺激的免费视频.| 亚洲人成网站高清观看| 亚洲欧美日韩高清在线视频| 人妻丰满熟妇av一区二区三区| 大又大粗又爽又黄少妇毛片口| av在线老鸭窝| 成人欧美大片| 一个人看的www免费观看视频| h日本视频在线播放| 国内精品一区二区在线观看| 内射极品少妇av片p| 少妇高潮的动态图| 久久久久国产精品人妻aⅴ院| 国产亚洲精品av在线| 波多野结衣巨乳人妻| 国产精品电影一区二区三区| 亚洲一区高清亚洲精品| 在线观看午夜福利视频| 综合色av麻豆| 有码 亚洲区| 美女大奶头视频| 国产精品综合久久久久久久免费| 婷婷精品国产亚洲av| 在线国产一区二区在线| 真实男女啪啪啪动态图| 又爽又黄无遮挡网站| 久久久色成人| 亚洲国产精品成人综合色| 欧美一区二区国产精品久久精品| 精品久久久久久久久亚洲 | 国产精品无大码| 免费在线观看影片大全网站| 亚洲,欧美,日韩| 天天一区二区日本电影三级| 亚洲成人久久性| 色噜噜av男人的天堂激情| 在线a可以看的网站| 欧美日韩瑟瑟在线播放| 亚洲性久久影院| 日韩在线高清观看一区二区三区 | 极品教师在线视频| 久久99热6这里只有精品| 最新在线观看一区二区三区| 18禁黄网站禁片午夜丰满| 亚洲欧美激情综合另类| 欧美3d第一页| 国产精品久久电影中文字幕| 国产在视频线在精品| 亚洲欧美日韩高清在线视频| 久久人妻av系列| 免费人成在线观看视频色| 少妇猛男粗大的猛烈进出视频 | 国产精品综合久久久久久久免费| 久久精品国产亚洲av涩爱 | 午夜老司机福利剧场| 国模一区二区三区四区视频| av视频在线观看入口| 欧美黑人巨大hd| 日本欧美国产在线视频| 日本撒尿小便嘘嘘汇集6| 国产精品久久久久久久久免| 免费黄网站久久成人精品| 一本精品99久久精品77| 久久人妻av系列| 欧美最黄视频在线播放免费| 在线观看舔阴道视频| 在线观看66精品国产| 一区二区三区激情视频| 亚洲专区中文字幕在线| 自拍偷自拍亚洲精品老妇| 国产高清视频在线观看网站| 国国产精品蜜臀av免费| 女人十人毛片免费观看3o分钟| 欧美黑人巨大hd| 精品一区二区三区视频在线| 熟女人妻精品中文字幕| 久久精品国产99精品国产亚洲性色| 极品教师在线视频| 尤物成人国产欧美一区二区三区| 99精品在免费线老司机午夜| 国产伦在线观看视频一区| av天堂中文字幕网| 精品人妻偷拍中文字幕| 最好的美女福利视频网| 国产免费av片在线观看野外av| 黄色女人牲交| 成人特级av手机在线观看| 亚洲av第一区精品v没综合| 成人性生交大片免费视频hd| 极品教师在线视频| 国产精品一区二区免费欧美| 日韩在线高清观看一区二区三区 | 日韩欧美三级三区| 欧美日韩乱码在线| 久久天躁狠狠躁夜夜2o2o| 亚洲国产色片| 久久精品国产亚洲网站| 校园春色视频在线观看| 中文字幕久久专区| 国产伦在线观看视频一区| 亚洲人成网站在线播放欧美日韩| 亚洲精品亚洲一区二区| 一区福利在线观看| 精品久久国产蜜桃| 男女之事视频高清在线观看| 午夜精品在线福利| 老司机福利观看| 免费人成在线观看视频色| 免费看光身美女| 人妻夜夜爽99麻豆av| 18禁黄网站禁片免费观看直播| 波多野结衣高清作品| 一个人免费在线观看电影| 亚洲va在线va天堂va国产| 日本黄色片子视频| 精品久久久久久久久久免费视频| 免费看光身美女| 22中文网久久字幕| 免费电影在线观看免费观看| 深爱激情五月婷婷| 免费观看的影片在线观看| 成年免费大片在线观看| 久久久久精品国产欧美久久久| 波多野结衣巨乳人妻| 悠悠久久av| 九九热线精品视视频播放| 久久午夜福利片| 一级黄片播放器| 乱码一卡2卡4卡精品| 亚洲性久久影院| 国产一区二区三区视频了| 午夜免费成人在线视频| 日本 av在线| 天堂√8在线中文| 女人十人毛片免费观看3o分钟| 麻豆国产av国片精品| 精品无人区乱码1区二区| 久久精品国产亚洲av天美| 人人妻人人看人人澡| 在线观看免费视频日本深夜| 亚洲精品在线观看二区| 91麻豆精品激情在线观看国产| 我要搜黄色片| 亚洲avbb在线观看| 精品福利观看| 亚洲国产精品sss在线观看| 99热只有精品国产| 欧美成人性av电影在线观看| bbb黄色大片| 国产在线精品亚洲第一网站| 亚洲va日本ⅴa欧美va伊人久久| 成人毛片a级毛片在线播放| 久久精品国产自在天天线| 老司机午夜福利在线观看视频| 日本撒尿小便嘘嘘汇集6| 能在线免费观看的黄片| 久久亚洲真实| 女人十人毛片免费观看3o分钟| a级毛片a级免费在线| 97碰自拍视频| 九九在线视频观看精品| 12—13女人毛片做爰片一| 97人妻精品一区二区三区麻豆| 深夜精品福利| 亚洲精品影视一区二区三区av| 欧美3d第一页| 一个人看的www免费观看视频| 天堂动漫精品| 给我免费播放毛片高清在线观看| 淫妇啪啪啪对白视频| 亚洲第一区二区三区不卡| 精品久久久久久久久av| 别揉我奶头~嗯~啊~动态视频| 国产伦精品一区二区三区四那| 深夜a级毛片| 免费高清视频大片| 性插视频无遮挡在线免费观看| 桃色一区二区三区在线观看| 亚洲在线自拍视频| 人妻制服诱惑在线中文字幕| 国产av在哪里看| 国产精品日韩av在线免费观看| 桃红色精品国产亚洲av| 国内久久婷婷六月综合欲色啪| 少妇熟女aⅴ在线视频| 热99在线观看视频| 97热精品久久久久久| 老师上课跳d突然被开到最大视频| 搞女人的毛片| 此物有八面人人有两片| 少妇的逼好多水| 国内精品宾馆在线| 久久久久久久久久久丰满 | 老熟妇乱子伦视频在线观看| 精品一区二区免费观看| 简卡轻食公司| 欧美+日韩+精品| 中文字幕av成人在线电影| 丰满人妻一区二区三区视频av| 天天躁日日操中文字幕| 精品99又大又爽又粗少妇毛片 | 久久人人爽人人爽人人片va| 亚洲国产色片| 国产aⅴ精品一区二区三区波| 亚洲av二区三区四区| 亚洲美女黄片视频| 99在线人妻在线中文字幕| 18禁裸乳无遮挡免费网站照片| 色尼玛亚洲综合影院| 亚洲国产精品合色在线| 久久国产乱子免费精品| 欧美日韩乱码在线| 久久精品国产99精品国产亚洲性色| 小蜜桃在线观看免费完整版高清| 嫩草影视91久久| 噜噜噜噜噜久久久久久91| 别揉我奶头~嗯~啊~动态视频| 欧美日韩国产亚洲二区| 日韩欧美三级三区| 亚洲成人久久爱视频| 成人一区二区视频在线观看| 999久久久精品免费观看国产| 亚洲一级一片aⅴ在线观看| 国产成人影院久久av| 欧美另类亚洲清纯唯美| 欧美不卡视频在线免费观看| 亚洲精品日韩av片在线观看| 99九九线精品视频在线观看视频| 夜夜夜夜夜久久久久| 特级一级黄色大片| 五月伊人婷婷丁香| 校园人妻丝袜中文字幕| 特大巨黑吊av在线直播| 看免费成人av毛片| 日本 av在线| 一个人观看的视频www高清免费观看| 亚洲人成网站在线播| 国产熟女欧美一区二区| 国产精品人妻久久久影院| 国产淫片久久久久久久久| 亚洲精华国产精华液的使用体验 | 国产成人av教育| 尾随美女入室| 亚洲精品日韩av片在线观看| 夜夜爽天天搞| 色尼玛亚洲综合影院| 永久网站在线| a级毛片免费高清观看在线播放| 成年免费大片在线观看| 欧美日韩瑟瑟在线播放| 99久久精品热视频| 久久九九热精品免费| 99久久精品一区二区三区| 国产av在哪里看| 一个人免费在线观看电影| 精品久久久久久成人av| 成人特级黄色片久久久久久久| 少妇的逼好多水| 在线看三级毛片| 成年版毛片免费区| 99热只有精品国产| 国产成人aa在线观看| 国产免费男女视频| 久久久成人免费电影| 亚洲av免费高清在线观看| 少妇的逼水好多| 亚洲美女黄片视频| 夜夜爽天天搞| 黄色欧美视频在线观看| 亚洲av中文av极速乱 | 在线国产一区二区在线| 国产精品无大码| 中国美女看黄片| 日韩大尺度精品在线看网址| 日日啪夜夜撸| 岛国在线免费视频观看| 观看免费一级毛片| 亚洲av中文av极速乱 | 不卡视频在线观看欧美| 精品一区二区免费观看| 国产精品美女特级片免费视频播放器| 国产精品自产拍在线观看55亚洲| 在线播放国产精品三级| 久久欧美精品欧美久久欧美| 亚洲四区av| 黄色配什么色好看| 美女黄网站色视频| 国产成人av教育| 日本熟妇午夜| 91麻豆精品激情在线观看国产| 熟女人妻精品中文字幕| 搞女人的毛片| 久久中文看片网| 午夜激情欧美在线| 国产精品乱码一区二三区的特点| 国产主播在线观看一区二区| 1024手机看黄色片| 伦精品一区二区三区| 久久精品国产清高在天天线| 国产成人av教育| .国产精品久久| 精品久久国产蜜桃| 女的被弄到高潮叫床怎么办 | 国产高清有码在线观看视频| 亚洲第一电影网av| 亚洲 国产 在线| 免费人成视频x8x8入口观看| 免费在线观看日本一区| 在线看三级毛片| 黄色日韩在线| 欧美日韩乱码在线| 久久人妻av系列| 色在线成人网| 久久午夜福利片| 成人欧美大片| 一级a爱片免费观看的视频| 日本一二三区视频观看| 色5月婷婷丁香| 99热只有精品国产| 非洲黑人性xxxx精品又粗又长| 亚洲欧美日韩东京热| 丰满的人妻完整版| 韩国av在线不卡| 日本成人三级电影网站| 九九热线精品视视频播放| 欧美国产日韩亚洲一区| 99久久久亚洲精品蜜臀av| 成人午夜高清在线视频| 免费在线观看日本一区| 97人妻精品一区二区三区麻豆| 午夜免费激情av| 熟妇人妻久久中文字幕3abv| 久久精品国产亚洲av香蕉五月| 麻豆成人午夜福利视频| 国产精品一区二区三区四区免费观看 | 男人狂女人下面高潮的视频| 变态另类成人亚洲欧美熟女| 成人特级av手机在线观看| 国产精品久久电影中文字幕| 在线天堂最新版资源| 欧美一区二区亚洲| 亚洲在线自拍视频| 精品久久久久久,| 99riav亚洲国产免费| 色5月婷婷丁香| 亚洲av美国av| 亚洲欧美精品综合久久99| 国产午夜福利久久久久久| 在线观看美女被高潮喷水网站| 观看免费一级毛片| 2021天堂中文幕一二区在线观| 男人的好看免费观看在线视频| 特级一级黄色大片| 亚洲国产欧洲综合997久久,| 午夜福利成人在线免费观看| 97碰自拍视频| 国产成人影院久久av| 伦精品一区二区三区| 变态另类丝袜制服| 又爽又黄a免费视频| 亚洲成人中文字幕在线播放| 简卡轻食公司| 欧美日韩综合久久久久久 | 成人性生交大片免费视频hd| 伊人久久精品亚洲午夜| 亚洲内射少妇av| 又爽又黄a免费视频| 国产男靠女视频免费网站| 好男人在线观看高清免费视频| 人妻制服诱惑在线中文字幕| 琪琪午夜伦伦电影理论片6080| 男女那种视频在线观看| 少妇被粗大猛烈的视频| 亚洲人成伊人成综合网2020| 我的老师免费观看完整版| 中国美女看黄片| 不卡视频在线观看欧美| 久久久久久久午夜电影| 久久国产精品人妻蜜桃| 日韩精品有码人妻一区| 国产亚洲欧美98| 日韩欧美 国产精品| 性色avwww在线观看| 国产精品国产高清国产av| 淫秽高清视频在线观看| 人妻丰满熟妇av一区二区三区| 精品一区二区免费观看| 两人在一起打扑克的视频| 日韩欧美 国产精品| 久久久久九九精品影院| 看十八女毛片水多多多| 超碰av人人做人人爽久久| 看片在线看免费视频| 天堂动漫精品| 天堂影院成人在线观看| 成人国产麻豆网| 精品午夜福利视频在线观看一区| ponron亚洲| 成年人黄色毛片网站| 在线a可以看的网站| 免费搜索国产男女视频| 欧美激情国产日韩精品一区| 色综合站精品国产| 成人一区二区视频在线观看| 男女边吃奶边做爰视频| 看黄色毛片网站| 超碰av人人做人人爽久久| netflix在线观看网站| 99在线人妻在线中文字幕| 天堂影院成人在线观看| 久久精品久久久久久噜噜老黄 | 色尼玛亚洲综合影院| 久久精品国产自在天天线| 一级av片app| 国产午夜精品久久久久久一区二区三区 | 悠悠久久av| 99在线视频只有这里精品首页| 精品一区二区三区视频在线观看免费| 国模一区二区三区四区视频| 国产乱人伦免费视频| 亚洲黑人精品在线| 色综合色国产| 亚洲aⅴ乱码一区二区在线播放| 两性午夜刺激爽爽歪歪视频在线观看| 欧美一区二区亚洲| 看片在线看免费视频| 亚洲内射少妇av| 啦啦啦韩国在线观看视频| 国产欧美日韩精品亚洲av| 人妻丰满熟妇av一区二区三区| 日本精品一区二区三区蜜桃| 亚洲在线自拍视频| 国产精品一区二区三区四区久久| 淫妇啪啪啪对白视频| 亚洲熟妇中文字幕五十中出| 亚洲三级黄色毛片| 长腿黑丝高跟| 麻豆一二三区av精品| a级毛片a级免费在线| 免费av观看视频| 一级毛片久久久久久久久女| 日本熟妇午夜| 亚洲欧美日韩卡通动漫| 亚洲色图av天堂| 久久午夜福利片| 在线天堂最新版资源| 午夜免费激情av| 亚洲第一区二区三区不卡| 日韩亚洲欧美综合| 国内少妇人妻偷人精品xxx网站| 美女 人体艺术 gogo| 嫩草影视91久久| x7x7x7水蜜桃| 国产精品无大码| 亚洲av不卡在线观看| 国产伦精品一区二区三区视频9| 亚洲精品乱码久久久v下载方式| 国产主播在线观看一区二区| 又爽又黄a免费视频| 国产精品,欧美在线| 日本一本二区三区精品| 国产欧美日韩精品亚洲av| 国产激情偷乱视频一区二区| 中文字幕熟女人妻在线| 欧美+日韩+精品| 久久亚洲真实| 久久香蕉精品热| 久久午夜亚洲精品久久| 国产爱豆传媒在线观看| bbb黄色大片| 2021天堂中文幕一二区在线观| 老司机午夜福利在线观看视频| 五月伊人婷婷丁香| 高清在线国产一区| 日本精品一区二区三区蜜桃| 美女被艹到高潮喷水动态| 我要看日韩黄色一级片|